Reduced bone resorption in toothless (osteopetrotic) rats--an abnormality of osteoblasts related to their inability to activate osteoclast activity in vitro.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Connective Tissue Research

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.3109/03008209609029201PMID 9084666
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Role of osteoblasts in hormonal control of bone resorption—A hypothesis

  2006cited by this paper
• Osteoblasts from the toothless (osteopetrotic) mutation in the rat are unable to direct bone resorption by normal osteoclasts in response to 1,25-dihydroxyvitamin D.

  1995cited by this paper
• Aberrant gene expression in cultured mammalian bone cells demonstrates an osteoblast defect in osteopetrosis

  1994cited by this paper
• Experimental studies of osteopetrosis in laboratory animals.

  1993cited by this paper
• Gene expression during skeletal development in three osteopetrotic rat mutations. Evidence for osteoblast abnormalities.

  1991cited by this paper
• Osteopetrosis in the rat: coexistence of reductions in osteocalcin and bone resorption.

  1990cited by this paper
• Osteoclast biology: lessons from mammalian mutations.

  1989cited by this paper
• Bone cell biology: the regulation of development, structure, and function in the skeleton.

  1988cited by this paper
• Osteopetrosis--multiple pathways for the interception of osteoclast function.

  1987cited by this paper
• 1,25-Dihydroxyvitamin D3 stimulates rat osteoblastic cells to release a soluble factor that increases osteoclastic bone resorption.

  1987cited by this paper
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper
• Osteopetrosis in the toothless rat: failure of osteoclast differentiation and function.

  1987cited by this paper
• Osteopetrosis--multiple pathways for the interception of osteoclast function.

  1987cited by this paper
• The effect of calcium-regulating hormones and prostaglandins on bone resorption by osteoclasts disaggregated from neonatal rabbit bones.

  1985cited by this paper
• Studies on congenital osteopetrosis in tl and ia rats using organ culture.

  1981cited by this paper
• Apparent nuclear localization of unoccupied receptors for 1,25-dihydroxyvitamin D3.

  1981cited by this paper
• The diagnosis and cure of neonatal osteopetrosis : experimental evidence from congenitally osteopetrotic (ia) rats

  1979cited by this paper
• Osteopetrosis in the toothless (t1) rat: presence of osteoclasts but failure to respond to parathyroid extract or to be cured by infusion of spleen or bone marrow cells from normal littermates.

  1977cited by this paper

• Exercise improves subchondral bone microenvironment through regulating bone-cartilage crosstalk

  2023cites this paper
• Bone phenotypes in rheumatology – there is more to bone than just bone

  2020cites this paper
• Bone physiology in human grafted and non-grafted extraction sockets--an immunohistochemical study.

  2013cites this paper
• Lessons from osteopetrotic mutations in animals: impact on our current understanding of osteoclast biology.

  2005cites this paper
• Localization of the Mutation Responsible for Osteopetrosis in the op Rat to a 1.5‐cM Genetic Interval on Rat Chromosome 10: Identification of Positional Candidate Genes by Radiation Hybrid Mapping

  2002cites this paper
• Evidence that the rat osteopetrotic mutation toothless (tl) is not in the TNFSF11 (TRANCE, RANKL, ODF, OPGL) gene.

  2002cites this paper
• The osteopetrotic mutation toothless (tl) is a loss-of-function frameshift mutation in the rat Csf1 gene: Evidence of a crucial role for CSF-1 in osteoclastogenesis and endochondral ossification

  2002cites this paper
• The toothless osteopetrotic rat has a normal vitamin D-binding protein-macrophage activating factor (DBP-MAF) cascade and chondrodysplasia resistant to treatments with colony stimulating factor-1 (CSF-1) and/or DBP-MAF.

  1999cites this paper